- Reuters
Structure's obesity drug reduces more weight than expected in study
Structure's once-daily oral drug, GSBR-1290, belongs to the same class of treatments as Novo Nordisk's blockbuster weight-loss drug Wegovy and Eli Lilly's Zepbound. Leerink analysts said in a note before the data that they expected weight loss of between 5% to 6% in the trial at the end of 12 weeks, compared with 6% to 7% from Lilly's trial of its oral weight loss drug orforglipron.
- The Telegraph
Molly Russell’s father calls for windfall tax on tech firms that do not prioritise children’s safety
The father of Molly Russell has called for a windfall tax to be imposed on tech firms for putting profits before children’s safety.
- Reuters
Vatican to EU election voters: don't dehumanise migrants
The Vatican's point man on migration and social justice on Monday urged EU citizens who might be tempted to vote for far-right parties in this week's European Parliament elections to remain sympathetic towards migrants and refugees. Far-right and conservative parties are expected to make gains in the June 6-9 vote, potentially tilting European Union politics towards a tougher approach on law and order and border security. The Vatican does not normally take political sides, but during his 11-year papacy, Pope Francis has consistently spoken up for migrants' rights and called for a more humanitarian approach by Western governments.
